Elocon: Advanced Topical Corticosteroid for Inflammatory Skin Conditions
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | $40.16 | $40.16 (0%) | 🛒 Add to cart |
| 2 | $30.12 | $80.32 $60.24 (25%) | 🛒 Add to cart |
| 3 | $26.77 | $120.48 $80.32 (33%) | 🛒 Add to cart |
| 4 | $25.10 | $160.64 $100.40 (38%) | 🛒 Add to cart |
| 5 | $24.10 | $200.80 $120.48 (40%) | 🛒 Add to cart |
| 6 | $23.43 | $240.96 $140.56 (42%) | 🛒 Add to cart |
| 7 | $22.95 | $281.12 $160.64 (43%) | 🛒 Add to cart |
| 8 | $21.34 | $321.28 $170.68 (47%) | 🛒 Add to cart |
| 9 | $20.08 | $361.45 $180.72 (50%) | 🛒 Add to cart |
| 10 | $19.08
Best per bottle | $401.61 $190.76 (52%) | 🛒 Add to cart |
Elocon (mometasone furoate) is a high-potency topical corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Formulated as a cream, ointment, or lotion, it delivers targeted anti-inflammatory, antipruritic, and vasoconstrictive actions directly to affected skin areas. Its optimized vehicle system enhances drug delivery while minimizing systemic absorption, making it a cornerstone in dermatological therapy for conditions like psoriasis, eczema, and allergic contact dermatitis. Clinicians favor Elocon for its efficacy-to-safety profile, especially in moderate to severe cases where rapid symptom control is essential.
Features
- Contains mometasone furoate 0.1% as the active pharmaceutical ingredient
- Available in multiple formulations: cream (water-based, nongreasy), ointment (occlusive, for drier lesions), and lotion (for scalp or hairy areas)
- Enhanced penetration technology for optimized epidermal delivery
- Low systemic absorption due to minimal percutaneous penetration
- Preservative-free in ointment form; cream contains phenoxyethanol as a preservative
- Suitable for once-daily application, supporting patient adherence
Benefits
- Rapid reduction of inflammation, erythema, and scaling within days of initiation
- Effective relief from intense pruritus, improving patient comfort and sleep quality
- Non-greasy and cosmetically elegant formulations enhance user compliance
- Reduced risk of skin atrophy compared to some older-generation corticosteroids
- Flexible dosing regimen allows for tailored treatment based on severity and body area
- Minimized potential for hypothalamic-pituitary-adrenal (HPA) axis suppression with appropriate use
Common use
Elocon is primarily prescribed for short-term treatment of inflammatory dermatoses responsive to corticosteroids. Common indications include atopic dermatitis (eczema), psoriasis (excluding widespread plaque psoriasis), seborrheic dermatitis, and lichen simplex chronicus. It is also used off-label for discoid lupus erythematosus, lichen planus, and nummular eczema. The lotion formulation is specifically advantageous for scalp psoriasis or seborrheic dermatitis due to its ease of application through hair.
Dosage and direction
Apply a thin film of Elocon to the affected area once daily. Gently rub in until absorbed. Use the smallest amount necessary to cover the treatment area; excessive application does not enhance efficacy and may increase adverse effects. Duration of treatment should not exceed 2 weeks for most adult cases and 1 week for pediatric patients (unless directed by a physician). For scalp conditions using the lotion, apply a few drops to the affected area and massage lightly without washing hair immediately after. Do not use under occlusive dressings unless specifically instructed, as this increases systemic absorption.
Precautions
- For external use only; avoid contact with eyes, mucous membranes, and broken skin
- Do not use on rosacea, perioral dermatitis, or acne vulgaris
- Use with caution on the face, groin, or axillae due to higher absorption rates
- Prolonged use may lead to skin atrophy, striae, telangiectasia, or contact dermatitis
- Discontinue if irritation or hypersensitivity occurs
- Not recommended for use under diapers in infants due to potential enhanced absorption
- Patients should be advised to avoid sunlight or UV exposure on treated areas
Contraindications
Elocon is contraindicated in patients with a known hypersensitivity to mometasone furoate or any component of the formulation. It should not be used in viral skin infections (e.g., herpes simplex, varicella), fungal infections, or untreated bacterial infections. Avoid use in patients with cutaneous tuberculosis. It is contraindicated in children under 2 years of age. Do not use if skin integrity is compromised by ulceration or severe erosion.
Possible side effect
Common local reactions may include burning, stinging, itching, or dryness at the application site. Less frequently, patients may experience folliculitis, hypertrichosis, or acneiform eruptions. With prolonged or inappropriate use, systemic effects such as HPA axis suppression, glucosuria, or hypertension may occur, though rare with recommended use. Allergic contact dermatitis is possible. If applied to large areas or under occlusion, systemic absorption may lead to corticosteroid side effects such as cushinoid features.
Drug interaction
No specific drug interactions have been clinically significant with topical Elocon. However, caution is advised when using other topical products concurrently (e.g., other corticosteroids, retinoids, or abrasive agents) due to potential additive irritation or enhanced absorption. Systemic interactions are unlikely but theoretically possible if significant absorption occurs, potentially altering effects of diabetic or antihypertensive medications.
Missed dose
If a dose is missed, apply as soon as remembered unless it is nearly time for the next application. Do not double the dose to catch up. Resume the regular once-daily schedule. Consistent daily use is ideal, but occasional missed doses are unlikely to significantly impact overall efficacy in short-term treatment.
Overdose
Topical overdose is unlikely to cause acute systemic effects. However, prolonged excessive application over large body surface areas or under occlusion may lead to systemic corticosteroid effects such as hypercorticism or adrenal suppression. Symptoms may include weight gain, edema, hypertension, or glucose intolerance. Treatment involves discontinuation of Elocon and supportive care. In case of accidental ingestion, seek medical attention immediately; symptoms may include nausea, vomiting, and electrolyte imbalance.
Storage
Store at room temperature (20–25°C). Do not freeze. Keep the tube tightly closed and away from direct sunlight or excessive heat. Keep out of reach of children. Do not use after the expiration date printed on the packaging. Discard any product that has changed color, consistency, or shows signs of contamination.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice. Always consult a healthcare provider for diagnosis and individualized treatment recommendations. Use only as directed by a physician. Safety and efficacy in pregnancy or lactation have not been fully established; use only if potential benefit justifies potential risk.
Reviews
Clinical studies demonstrate Elocon’s superiority to placebo and non-inferiority to other mid- to high-potency steroids. In a 3-week trial involving patients with moderate eczema, 78% showed significant improvement with once-daily Elocon cream versus 22% with vehicle. Dermatologists frequently report high satisfaction due to its rapid action and low incidence of side effects when used appropriately. Patient reviews often highlight relief from itching and ease of application, though some note mild initial stinging.